Literature DB >> 25451855

Characterization of sleep disorders in patients with E200K familial Creutzfeldt-Jakob disease.

Oren S Cohen1, Joab Chapman, Amos D Korczyn, Naama Warman-Alaluf, Yael Orlev, Gili Givaty, Zeev Nitsan, Shmuel Appel, Hanna Rosenmann, Esther Kahana, Dalia Shechter-Amir.   

Abstract

The largest cluster of E200K familial Creutzfeldt-Jakob disease (fCJD) which occurs is in Jews of Libyan origin in Israel. Insomnia is a very common early complaint in those patients and may even be the presenting symptom. The aim of this study was to assess and characterize sleep pathology in E200K fCJD patients. To do so, sleep studies of 10 consecutive fCJD patients were compared with those of 39 age and gender-matched controls. All patients presented pathological sleep characterized by fragmentation of sleep, loss of sleep spindles and reduced REM sleep amount. Respiration was characterized by irregular rhythm, periodic breathing, apneas and hypopneas, either central or obstructive. EMG recordings revealed repeated movements in sleep, with loss of REM atonia. Comparing to controls, a significant decrease of total sleep time, sleep efficacy and slow-wave sleep as well as a significant increase in the number of awakenings, apnea-hypopnea index and mixed and central apneas were evident in CJD patients. Comparison of two sequential sleep studies in one patient revealed a 40 % reduction of the total sleep time, a 40 % reduction in sleep efficacy and a 40-fold increase of the number of arousals in the second study. A significant correlation was found between the disease severity, as reflected by the CJD Neurological Scale and Periodic leg movement index. These definite and characteristic sleep pathologies in patients with fCJD associated with the E200K mutation may serve as a new diagnostic tool in the disease.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25451855     DOI: 10.1007/s00415-014-7593-3

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  24 in total

1.  Proposed supplements and amendments to 'A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects', the Rechtschaffen & Kales (1968) standard.

Authors:  T Hori; Y Sugita; E Koga; S Shirakawa; K Inoue; S Uchida; H Kuwahara; M Kousaka; T Kobayashi; Y Tsuji; M Terashima; K Fukuda; N Fukuda
Journal:  Psychiatry Clin Neurosci       Date:  2001-06       Impact factor: 5.188

2.  Demyelinating peripheral neuropathy in Creutzfeldt-Jakob disease.

Authors:  M Y Neufeld; J Josiphov; A D Korczyn
Journal:  Muscle Nerve       Date:  1992-11       Impact factor: 3.217

Review 3.  Prion diseases.

Authors:  R S G Knight; R G Will
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-03       Impact factor: 10.154

4.  Pruritus in familial Creutzfeldt-Jakob disease: a common symptom associated with central nervous system pathology.

Authors:  Oren S Cohen; Joab Chapman; Hedok Lee; Zeev Nitsan; Shmuel Appel; Chen Hoffman; Hanna Rosenmann; Amos D Korczyn; Isak Prohovnik
Journal:  J Neurol       Date:  2010-08-21       Impact factor: 4.849

5.  Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei.

Authors:  E Lugaresi; R Medori; P Montagna; A Baruzzi; P Cortelli; A Lugaresi; P Tinuper; M Zucconi; P Gambetti
Journal:  N Engl J Med       Date:  1986-10-16       Impact factor: 91.245

6.  Mutation of the prion protein in Libyan Jews with Creutzfeldt-Jakob disease.

Authors:  K Hsiao; Z Meiner; E Kahana; C Cass; I Kahana; D Avrahami; G Scarlato; O Abramsky; S B Prusiner; R Gabizon
Journal:  N Engl J Med       Date:  1991-04-18       Impact factor: 91.245

7.  The FAB: a Frontal Assessment Battery at bedside.

Authors:  B Dubois; A Slachevsky; I Litvan; B Pillon
Journal:  Neurology       Date:  2000-12-12       Impact factor: 9.910

8.  Insomnia associated with thalamic involvement in E200K Creutzfeldt-Jakob disease.

Authors:  Ana Lia Taratuto; P Piccardo; E G Reich; S G Chen; G Sevlever; M Schultz; A A Luzzi; M Rugiero; G Abecasis; M Endelman; A M Garcia; S Capellari; Z Xie; E Lugaresi; P Gambetti; S R Dlouhy; B Ghetti
Journal:  Neurology       Date:  2002-02-12       Impact factor: 9.910

9.  Sporadic Creutzfeldt-Jakob disease: magnetic resonance imaging and clinical findings.

Authors:  B Meissner; K Körtner; M Bartl; U Jastrow; B Mollenhauer; A Schröter; M Finkenstaedt; O Windl; S Poser; H A Kretzschmar; I Zerr
Journal:  Neurology       Date:  2004-08-10       Impact factor: 9.910

10.  Thalamo-striatal diffusion reductions precede disease onset in prion mutation carriers.

Authors:  Hedok Lee; Hanna Rosenmann; Joab Chapman; Peter B Kingsley; Chen Hoffmann; Oren S Cohen; Esther Kahana; Amos D Korczyn; Isak Prohovnik
Journal:  Brain       Date:  2009-03-24       Impact factor: 13.501

View more
  2 in total

Review 1.  The Role of the Mammalian Prion Protein in the Control of Sleep.

Authors:  Amber Roguski; Andrew C Gill
Journal:  Pathogens       Date:  2017-11-17

2.  The genetic Creutzfeldt-Jakob disease with E200K mutation: analysis of clinical, genetic and laboratory features of 30 Chinese patients.

Authors:  Li-Ping Gao; Qi Shi; Kang Xiao; Jing Wang; Wei Zhou; Cao Chen; Xiao-Ping Dong
Journal:  Sci Rep       Date:  2019-02-12       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.